Mechanisms of anemia in SHP-1 protein tyrosine phosphatase-deficient "viable motheaten" mice

Experimental Hematology

Volumn 31, Issue 3, 2003, Pages 234-243

  Lyons, Bonnie L ^a   Lynes, Michael A ^b   Burzenski, Lisa ^a   Joliat, Melissa J ^a   Hadjout, Nacima ^b   Shultz, Leonard D ^a  

^a JACKSON LABORATORY   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD71 ANTIGEN; ERYTHROPOIETIN; GLUTATHIONE; ISOPROTEIN; LIPOCORTIN 5; OXIDIZING AGENT; PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; UNCLASSIFIED DRUG;

ANEMIA; ANIMAL CELL; ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; COOMBS TEST; ERYTHROCYTE; FLOW CYTOMETRY; HEMATOLOGY; LIPID PEROXIDATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION;

EID: 0344406219     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)01031-7     Document Type: Article

References (39)

1. Cotran R. Red cells and bleeding disorders. Cotran R.S., Kumar V., Collins T. Robbins Pathologic Basis of Disease. 6th ed:1999;601-643 W.B. Saunders, Philadelphia.
2. Baxter A.G., Mandel T.E. Hemolytic anemia in non-obese diabetic mice. Eur J Immunol. 21:1991;2051-2055.
3. Sen G., Mukhopadhyay R., Ghosal J., Biswas T. Oxidative damage of erythrocytes. a possible mechanism for premature hemolysis in experimental visceral leishmaniasis in hamsters Ann Hematol. 80:2001;32-37.
4. Shultz L.D., Schweitzer P.A., Rajan T.V.et al. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell. 73:1993;1445-1454.
5. McCulloch J., Siminovitch K.A. Involvement of the protein tyrosine phosphatase PTP1C in cellular physiology, autoimmunity and oncogenesis. Adv Exp Med Biol. 365:1994;245-254.
6. Zhang J., Somani A.K., Siminovitch K.A. Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling. Semin Immunol. 12:2000;361-378.
7. Shultz L.D., Coman D.R., Bailey C.L., Beamer W.G., Sidman C.L. "Viable motheaten," a new allele at the motheaten locus. I. Pathology. Am J Pathol. 116:1984;179-192.
8. Shultz L.D., Rajan T.V., Greiner D.L. Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency. Trends Biotechnol. 15:1997;302-307.
9. Wickrema A., Chen F., Namin F.et al. Defective expression of the SHP-1 phosphatase in polycythemia vera. Exp Hematol. 27:1999;1124-1132.
10. Van Zant G., Shultz L. Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev). Exp Hematol. 17:1989;81-87.
11. Arvieux J., Roussel B., Ponard D., Colomb M.G. Reactivity patterns of anti-phospholipid antibodies in systemic lupus erythematosus sera in relation to erythrocyte binding and complement activation. Clin Exp Immunol. 84:1991;466-471.
12. Arvieux J., Schweizer B., Roussel B., Colomb M.G. Autoimmune haemolytic anaemia due to anti-phospholipid antibodies. Vox Sang. 61:1991;190-195.
13. Bailey N.C., Bona A., Dikman S., Bonilla F., Alt F.W., Bona C. Correlation between the occurrence of lupus nephritis, anti-erythrocyte autoantibodies and V kappa haplotype in NZB x 129/J and NZB x SM/J recombinant inbred murine strains. Eur J Immunol. 21:1991;959-965.
14. Pani G., Siminovitch K.A., Paige C.J. The motheaten mutation rescues B cell signaling and development in CD45-deficient mice. J Exp Med. 186:1997;581-588.
15. Kitamura D., Roes J., Kuhn R., Rajewsky K. A B-cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature. 350:1991;423-426.
16. Palmiter R.D., Sandgren E.P., Koeller D.M., Brinster R.L. Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice. Mol Cell Biol. 13:1993;5266-5275.
17. Masters B.A., Kelly E.J., Quaife C.J., Brinster R.L., Palmiter R.D. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc Natl Acad Sci U S A. 91:1994;584-588.
18. Emmendorffer A., Hecht M., Lohmann-Matthes M.L., Roesler J. A fast and easy method to determine the production of reactive oxygen intermediates by human and murine phagocytes using dihydrorhodamine 123. J Immunol Methods. 131:1990;269-275.
19. Jain S.K. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J Biol Chem. 264:1989;21340-21345.
20. Sherwood J.B., Goldwasser E. A radioimmunoassay for erythropoietin. Blood. 54:1979;885-893.
21. Ballas S.K., Tabbara K.F., Murphy D.L., Mohandas N., Clark M.R., Shohet S.B. Erythrocyte deformability changes in autoimmune hemolytic anemia during development of NZB mice and their (NZB/NZW)F1 hybrid. J Clin Lab Immunol. 16:1985;217-222.
22. Macpherson A.J., Lamarre A., McCoy K.et al. IgA production without mu or delta chain expression in developing B cells. Nat Immunol. 2:2001;625-631.
23. Connor J., Pak C.C., Schroit A.J. Exposure of phosphatidylserine in the outer leaflet of human red blood cells. Relationship to cell density, cell age, and clearance by mononuclear cells. J Biol Chem. 269:1994;2399-2404.
24. Boas F.E., Forman L., Beutler E. Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc Natl Acad Sci U S A. 95:1998;3077-3081.
25. Lok C.N., Ponka P. Identification of an erythroid active element in the transferrin receptor gene. J Biol Chem. 275:2000;24185-24190.
26. Oldenborg P.A., Zheleznyak A., Fang Y.F., Lagenaur C.F., Gresham H.D., Lindberg F.P. Role of CD47 as a marker of self on red blood cells. Science. 288:2000;2051-2054.
27. Kruger J., Butler J.R., Cherapanov V.et al. Deficiency of Src homology 2-containing phosphatase 1 results in abnormalities in murine neutrophil function. studies in motheaten mice J Immunol. 165:2000;5847-5859.
28. Zhang J., Somani A.K., Yuen D., Yang Y., Love P.E., Siminovitch K.A. Involvement of the SHP-1 tyrosine phosphatase in regulation of T cell selection. J Immunol. 163:1999;3012-3021.
29. Sharlow E.R., Pacifici R., Crouse J., Batac J., Todokoro K., Wojchowski D.M. Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells. Blood. 90:1997;2175-2187.
30. Asimakopoulos F.A., Hinshelwood S., Gilbert J.G.et al. The gene encoding hematopoietic cell phosphatase (SHP-1) is structurally and transcriptionally intact in polycythemia vera. Oncogene. 14:1997;1215-1222.
31. Klingmuller U., Lorenz U., Cantley L.C., Neel B.G., Lodish H.F. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell. 80:1995;729-738.
32. Guyton A.C., Hall J.E. Transport of oxygen and carbon dioxide in the blood and body fluids. Guyton A.C., Hall J.E. Textbook of Medical Physiology, 10 ed. 2000;463-473 W.B. Saunders, Philadelphia.
33. Johnson R.M., Ravindranath Y., el-Alfy M., Goyette G. Jr. Oxidant damage to erythrocyte membrane in glucose-6-phosphate dehydrogenase deficiency. correlation with in vivo reduced glutathione concentration and membrane protein oxidation Blood. 83:1994;1117-1123.
34. Rahman M.T., De Ley M. Metallothionein isogene transcription in red blood cell precursors from human cord blood. Eur J Biochem. 268:2001;849-856.
35. Chukhlovin A.B. Apoptosis and red blood cell echinocytosis. common features Scanning Microsc. 10:1996;795-803.
36. Oldenborg P.A., Gresham H.D., Lindberg F.P. CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis. J Exp Med. 193:2001;855-862.
37. Fossati-Jimack L., Azeredo da Silveira S, Moll Tet al. Selective increase of autoimmune epitope expression on aged erythrocytes in mice. implications in anti-erythrocyte autoimmune responses J Autoimmun. 18:2002;17-25.
38. Balasubramanian K., Bevers E.M., Willems G.M., Schroit A.J. Binding of annexin V to membrane products of lipid peroxidation. Biochemistry. 40:2001;8672-8676.
39. Liu J., Liu Y., Habeebu S.S., Klaassen C.D. Metallothionein-null mice are highly susceptible to the hematotoxic and immunotoxic effects of chronic CdCl2 exposure. Toxicol Appl Pharmacol. 159:1999;98-108.